Related Experiment Video
Updated: Jun 17, 2026
05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
Obesity treatment: novel peripheral targets.
Benjamin C T Field1, Owais B Chaudhri, Stephen R Bloom
1Department of Investigative Medicine, Imperial College London, Hammersmith Hospital Campus, London, UK.
British Journal of Clinical Pharmacology
|December 17, 2009
Summary
Gut hormones like GLP-1 regulate food intake and body weight. This review explores their role in energy homeostasis and potential as anti-obesity drug targets.
Area of Science:
- * Endocrinology and neurobiology of energy balance.
- * Gastrointestinal and metabolic signaling pathways.
Background:
- * Energy homeostasis involves complex regulation by the hypothalamus, brainstem, and reward circuits.
- * Cognitive, humoral, and neuronal signals influence food intake and body weight.
- * Gut hormones play a critical role in short-term appetite regulation.
Purpose of the Study:
- * To review the role of gut hormones in short- and long-term food intake regulation.
- * To discuss the current development of obesity therapies targeting gut hormones.
Main Methods:
- * Literature review of studies on gut hormones and energy homeostasis.
- * Analysis of current research on gut hormone-based anti-obesity drug development.
Main Results:
- * Several gut hormones (e.g., GLP-1, PYY, ghrelin) are key regulators of food intake.
- * These hormones represent promising targets for novel anti-obesity medications.
Conclusions:
- * Gut hormones are crucial for maintaining energy balance.
- * Targeting gut hormones offers a potential therapeutic strategy for obesity treatment.
Related Concept Videos
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:21Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
01:27Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...